Delta Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History

Delta Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $1.75 Million - $2.73 Million	-47,933 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$39.26 - $52.73 $1.88 Million - $2.53 Million	47,933 New	47,933 $2.32 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $1.72 Million - $2.55 Million	-54,335 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $1.97 Million - $2.79 Million	54,335 New	54,335 $2.32 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Investment Management, LLC with notifications on news.